Showing results (271-280 of 2,262) with videos related to

Sort By:
Pageof 227
Frontiers in Immunology|April 17, 2024
The role and mechanism of TXNDC5 in disease progressionMingxia Jiao, Yeyong Zhang, Xie Song, et al.
Molecular Biology Reports|June 30, 2026
CC chemokines in epithelial ovarian cancer: orchestrating the metastatic microenvironment and therapy resistanceBing Xu, Jinhan Yao, Mengru Han, et al.
Journal of Environmental Sciences (China)|August 2, 2014
Large-scale synthesis of hierarchical flowerlike boehmite architecturesBing Xu, Jing Wang, Hongbo Yu, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|January 15, 2011
Adaptive identification of time delays in nonlinear dynamical modelsHuanfei Ma, Bing Xu, Wei Lin, et al.
Science China. Life Sciences|August 11, 2010
Biomass carbon stocks in China's forests between 2000 and 2050: a prediction based on forest biomass-age relationshipsBing Xu, ZhaoDi Guo, ShiLong Piao, et al.
Beilstein Journal of Organic Chemistry|March 31, 2011
Exceptionally small supramolecular hydrogelators based on aromatic-aromatic interactionsJunfeng Shi, Yuan Gao, Zhimou Yang, et al.
Life Sciences|May 30, 2019
Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery diseaseHongli Wang, Na Zhang, Guiru Li, et al.
Journal of the American Chemical Society|October 10, 2017
Self-Assembling Ability Determines the Activity of Enzyme-Instructed Self-Assembly for Inhibiting Cancer CellsZhaoqianqi Feng, Huaimin Wang, Xiaoyi Chen, et al.
Chemical Communications (Cambridge, England)|October 3, 2006
The first pamidronate containing polymer and copolymerLing Wang, Min Zhang, Zhimou Yang, et al.
Acta Pharmaceutica Sinica. B|September 15, 2021
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challengesMatthew Behr, Jing Zhou, Bing Xu, et al.
Pageof 227